KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Shares Issued (2018 - 2025)

Vir Biotechnology (VIR) has disclosed Shares Issued for 8 consecutive years, with -$408000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued fell 113.32% to -$408000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, down 64.15% year-over-year, with the annual reading at $1.3 million for FY2025, 64.15% down from the prior year.
  • Shares Issued hit -$408000.0 in Q4 2025 for Vir Biotechnology, down from $510000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $3.7 million in Q3 2021 to a low of -$1.9 million in Q3 2024.
  • Historically, Shares Issued has averaged $1.3 million across 5 years, with a median of $879000.0 in 2023.
  • Biggest five-year swings in Shares Issued: soared 1544.76% in 2021 and later crashed 113.32% in 2025.
  • Year by year, Shares Issued stood at $3.4 million in 2021, then tumbled by 111.04% to -$380000.0 in 2022, then surged by 331.32% to $879000.0 in 2023, then soared by 248.35% to $3.1 million in 2024, then tumbled by 113.32% to -$408000.0 in 2025.
  • Business Quant data shows Shares Issued for VIR at -$408000.0 in Q4 2025, $510000.0 in Q3 2025, and $649000.0 in Q2 2025.